Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

459 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study.
Kuna P, Bachert C, Nowacki Z, van Cauwenberge P, Agache I, Fouquert L, Roger A, Sologuren A, Valiente R; Bilastine International Working Group. Kuna P, et al. Among authors: roger a. Clin Exp Allergy. 2009 Sep;39(9):1338-47. doi: 10.1111/j.1365-2222.2009.03257.x. Epub 2009 May 4. Clin Exp Allergy. 2009. PMID: 19438584 Clinical Trial.
Randomized dose-response study of subcutaneous immunotherapy with a Dermatophagoides pteronyssinus extract in patients with respiratory allergy.
Moreno V, Alvariño M, Rodríguez F, Roger A, Peña-Arellano MI, Lleonart R, Pagán JA, Navarro JA, Navarro LA, Vidal C, Ponte-Tellechea A, Gómez-Fernández MC, Madariaga-Goirigolzarri B, Asturias JA, Hernández-Fernandez de Rojas D. Moreno V, et al. Among authors: roger a. Immunotherapy. 2016;8(3):265-77. doi: 10.2217/imt.15.124. Epub 2016 Jan 12. Immunotherapy. 2016. PMID: 26757045 Clinical Trial.
Clinical trial to assess tolerability and subrogate efficacy effects of an abbreviated schedule with house dust mites mixture subcutaneous immunotherapy.
Antépara I, Roger A, Bernedo N, Lleonart R, Rodríguez F, Madariaga B, Asturias JA, Begoña L, Martínez A, Landeta A, Gómez-Fernández MC. Antépara I, et al. Among authors: roger a. Eur Ann Allergy Clin Immunol. 2021 Mar;53(2):67-74. doi: 10.23822/EurAnnACI.1764-1489.140. Epub 2021 Mar 1. Eur Ann Allergy Clin Immunol. 2021. PMID: 32223886 Free article.
Effectiveness and safety of a microcrystalline tyrosine-adjuvanted Dermatophagoides pteronyssinus allergoid immunotherapy in adult patients with allergic asthma and rhinitis: A real-life prospective observational study.
Padró C, Gutiérrez D, Moreno F, Parra A, Rial MJ, Lleonart R, Torán-Barona C, Justicia JL, Roger A. Padró C, et al. Among authors: roger a. Immun Inflamm Dis. 2022 May;10(5):e585. doi: 10.1002/iid3.585. Immun Inflamm Dis. 2022. PMID: 35478444 Free PMC article.
459 results